Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 20, 2019 08:00 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences Named to the Russell 3000® Index

RALEIGH, N.C., June 20, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is set to be added to the broad-market Russell 3000® Index as well as the Russell 2000® Index...
May 06, 2019 16:05 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences Reports Strong First Quarter 2019 Results and Raises BELBUCA® Full-Year Expectations

BELBUCA® Net Sales Increased by 134% versus Prior Year to All-time High of $18.7 MillionSymproic® Acquisition and Commercial Integration Successfully CompletedCompany Raises Full-Year BELBUCA Net...
April 25, 2019 16:30 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences to Report First Quarter 2019 Financial Results

RALEIGH, N.C., April 25, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
February 04, 2019 08:03 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA®

RALEIGH, N.C., Feb. 04, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
January 15, 2019 07:30 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences Appoints Terry Coelho as Chief Financial Officer

RALEIGH, N.C., Jan. 15, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
November 01, 2018 16:10 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences Announces Further Significant Expanded Preferred Coverage For BELBUCA®

More than 100 million Covered Lives Now Have Preferred Access to BELBUCA RALEIGH, N.C., Nov. 01, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly...
October 29, 2018 08:30 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences Announces Changes to its Executive Leadership Team

James Vollins joins the Company in role of General Counsel, Chief Compliance Officer, and Corporate Secretary Ernest De Paolantonio, Chief Financial Officer announces plan to retire by mid-2019 ...
October 23, 2018 08:00 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences to Report Third Quarter 2018 Financial Results on November 8, 2018

RALEIGH, N.C., Oct. 23, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
July 24, 2018 16:30 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences to Report Second-Quarter 2018 Financial Results on August 9, 2018

RALEIGH, N.C., July 24, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced that it will report its second quarter 2018 financial results after the close...
May 23, 2018 08:00 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences to Present at the Jefferies 2018 Global Healthcare Conference

RALEIGH, N.C., May 23, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine,...